Ionis Pharmaceuticals Q1 2026 Earnings EPS Beat Driven by Cost Discipline Stock Holds Steady MLAB Q1 2026 Earnings Earnings Per Share Surges Past Estimates by Over 130 KTCC Q1 2026 Earnings Loss Per Share of 026 as Stock Declines 17 SRBK Q3 2025 Earnings Positive Earnings Despite Limited Disclosures PSO Q4 2025 Earnings Modest EPS Beat Highlights Steady Execution JD Q1 2026 Earnings EPS Misses Estimates Stock Dips 3